Display options
Cite
Bei Y, Duong-Quy S, Hua-Huy T, et al. Activation of RhoA/Rho-kinase pathway accounts for pulmonary endothelial dysfunction in patients with chronic obstructive pulmonary disease. Physiol Rep. 2013;1(5):e00105doi: 10.1002/phy2.105.
Bei, Y., Duong-Quy, S., Hua-Huy, T., Dao, P., Le-Dong, N. N., & Dinh-Xuan, A. T. (2013). Activation of RhoA/Rho-kinase pathway accounts for pulmonary endothelial dysfunction in patients with chronic obstructive pulmonary disease. Physiological reports, 1(5), e00105. https://doi.org/10.1002/phy2.105
Bei, Yihua, et al. "Activation of RhoA/Rho-kinase pathway accounts for pulmonary endothelial dysfunction in patients with chronic obstructive pulmonary disease." Physiological reports vol. 1,5 (2013): e00105. doi: https://doi.org/10.1002/phy2.105
Bei Y, Duong-Quy S, Hua-Huy T, Dao P, Le-Dong NN, Dinh-Xuan AT. Activation of RhoA/Rho-kinase pathway accounts for pulmonary endothelial dysfunction in patients with chronic obstructive pulmonary disease. Physiol Rep. 2013 Oct;1(5):e00105. doi: 10.1002/phy2.105. Epub 2013 Oct 20. PMID: 24303177; PMCID: PMC3841041.
Copy Download .nbib Format: NLM
Share it on

Physiol Rep. 2013 Oct;1(5):e00105. doi: 10.1002/phy2.105. Epub 2013 Oct 20.

Activation of RhoA/Rho-kinase pathway accounts for pulmonary endothelial dysfunction in patients with chronic obstructive pulmonary disease.

Physiological reports

Yihua Bei, Sy Duong-Quy, Thong Hua-Huy, Pierre Dao, Nhat-Nam Le-Dong, Anh Tuan Dinh-Xuan

Affiliations

  1. Medical School, Assistance Publique Hôpitaux de Paris, Service de Physiologie, Paris Descartes University EA 2511, Hôpital Cochin, 27 Rue du faubourg Saint-Jacques, 75014, Paris, France ; Clinical and Translational Research Center, Tongji University School of Medicine and Shanghai East Hospital 150 Jimo Road, Shanghai, 200120, China.

PMID: 24303177 PMCID: PMC3841041 DOI: 10.1002/phy2.105

Abstract

Recent evidence suggests that activation of RhoA/Rho-kinase accounts for systemic and pulmonary endothelial dysfunction in smokers with normal lung function. However, its role in patients with chronic obstructive pulmonary disease (COPD) has not yet been investigated. The aim of this study was to evaluate the regulation of RhoA/Rho-kinase pathway and pulmonary endothelial dysfunction in patients with COPD. Pulmonary arteries were obtained from nonsmokers (control subjects) and patients with nonhypoxemic and hypoxemic COPD (n = 6-7/group). Endothelium-dependent and -independent relaxations were evaluated by acetylcholine and sodium nitroprusside, respectively. Gene and protein expressions of endothelial nitric oxide synthase (eNOS) were measured by RT-PCR, Western blot, and immunohistochemistry. Nitrate, cGMP, and endothelin-1 (ET-1) concentrations, as well as Rho-kinase activity were measured by ELISA. Protein expressions of total RhoA and GTP-RhoA were measured by Western blot and pull-down assay, respectively. Endothelium-dependent relaxation, and nitrate and cGMP levels were significantly reduced in pulmonary arteries of COPD patients as compared with control subjects. Conversely, activity of RhoA/Rho-kinase was increased in pulmonary arteries of COPD patients as compared with control subjects. In patients with COPD, pulmonary endothelial dysfunction was related to the downregulation of eNOS activity and upregulation of RhoA/Rho-kinase activity.

Keywords: COPD; Rho-kinases; RhoA; eNOS; endothelial dysfunction

References

  1. Am J Respir Crit Care Med. 2013 Feb 15;187(4):347-65 - PubMed
  2. Am J Respir Crit Care Med. 2001 Aug 15;164(4):709-13 - PubMed
  3. N Engl J Med. 1991 May 30;324(22):1539-47 - PubMed
  4. Am J Physiol Heart Circ Physiol. 2004 Oct;287(4):H1495-500 - PubMed
  5. Circ Res. 2005 Dec 9;97(12):1232-5 - PubMed
  6. Circulation. 2004 Jan 20;109(2):159-65 - PubMed
  7. Am J Respir Cell Mol Biol. 1998 Nov;19(5):819-25 - PubMed
  8. J Biol Chem. 1998 Sep 11;273(37):24266-71 - PubMed
  9. Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2630-5 - PubMed
  10. Eur Respir J. 2006 Feb;27(2):397-412 - PubMed
  11. J Hypertens. 2001 May;19(5):891-7 - PubMed
  12. Am J Physiol Lung Cell Mol Physiol. 2004 Oct;287(4):L665-72 - PubMed
  13. Arterioscler Thromb Vasc Biol. 2004 Oct;24(10):1842-7 - PubMed
  14. Pharmacol Ther. 2013 Mar;137(3):352-64 - PubMed
  15. Chest. 2007 Apr;131(4):1006-12 - PubMed
  16. Eur Respir J. 2007 Feb;29(2):279-83 - PubMed
  17. Circ Res. 2005 Jul 22;97(2):185-91 - PubMed
  18. Med Klin (Munich). 1999 Apr 15;94(4):211-8 - PubMed
  19. Am J Physiol. 1998 Jun;274(6):L908-13 - PubMed
  20. Stroke. 2005 Oct;36(10):2251-7 - PubMed
  21. Am J Respir Crit Care Med. 1994 Feb;149(2 Pt 1):423-9 - PubMed
  22. Eur Respir J. 2003 May;21(5):892-905 - PubMed
  23. Eur Respir J. 2002 Apr;19(4):632-8 - PubMed
  24. Chest. 2008 Oct;134(4):808-814 - PubMed
  25. Am J Physiol Lung Cell Mol Physiol. 2008 Sep;295(3):L515-29 - PubMed
  26. Circulation. 2002 Jul 2;106(1):57-62 - PubMed
  27. Thorax. 2004 Aug;59(8):713-21 - PubMed
  28. Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1605-11 - PubMed
  29. Hypertension. 2006 Aug;48(2):278-85 - PubMed
  30. Drugs. 2009 Jun 18;69(9):1153-71 - PubMed
  31. Vascul Pharmacol. 2013 Mar;58(3):202-10 - PubMed
  32. Eur Respir J. 2011 Feb;37(2):349-55 - PubMed
  33. Hypertens Res. 2010 Apr;33(4):354-9 - PubMed
  34. Lancet. 1997 May 24;349(9064):1498-504 - PubMed

Publication Types